EPIZON
Live / Registered — Registered (as of 18 Feb 2020)
What this means for you
Registered since 18 Feb 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86822653
- Registration number
- 5991378
- Mark type
- Design + words
- Filed
- 17 Nov 2015
- Published for opposition
- 01 Nov 2016
- Registered
- 18 Feb 2020
- Attorney of record
- Alexander P. Montgomery
Goods and services
- Class 042 — Scientific and technological services: development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals and drugs, excluding devices or drug systems for the delivery of pharmaceuticals for the treatment of allergic reactions, anaphylaxis, or asthma and pharmaceuticals for the treatment of allergic reactions, anaphylaxis or asthma
Owner
- Epizon Pharma, Inc., Woodbridge, CT, US
- Epizon Pharma, Inc., Woodbridge, CT, US
- Epizon Pharma, Inc., Woodbridge, CT, US
Prosecution history
- 18 Feb 2026 — TEAS SECTION 8 & 15 RECEIVED
- 18 Feb 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 18 Feb 2020 — REGISTERED-PRINCIPAL REGISTER
- 17 Jan 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Jan 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Dec 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Dec 2019 — USE AMENDMENT FILED
- 26 Dec 2019 — TEAS STATEMENT OF USE RECEIVED
- 09 Jul 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jul 2019 — SOU EXTENSION 5 GRANTED
- 26 Jun 2019 — SOU EXTENSION 5 FILED
- 26 Jun 2019 — SOU TEAS EXTENSION RECEIVED
- 04 Jan 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Jan 2019 — CORRECTED NOA E-MAILED
- 03 Jan 2019 — SOU EXTENSION 4 GRANTED